Tolingin, Mary Joy .
HRN: 15-85-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2023
METRONIDAZOLE 500MG (TAB)
11/25/2023
12/02/2023
PO
500mg
TID X 7 Days
Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes